Statistics for Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis
Total visits
views | |
---|---|
Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis | 83 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
198_2020_Article_5388.pdf | 92 |
java.util.UUID:fba8502e-cb74-45ca-9406-24cc0c4a56b2 | 53 |
java.util.UUID:58a0c358-213a-45a9-b235-58ef6b174d0f | 6 |
java.util.UUID:d29b8475-04a9-4bda-9ca9-07c60df3c805 | 6 |
Top country views
views | |
---|---|
United States | 67 |
Vietnam | 2 |
China | 1 |
Cambodia | 1 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 36 |
Houston | 7 |
Fairfield | 5 |
Lanham | 4 |
Chicago | 3 |
Cambridge | 2 |
Dong Ket | 2 |
Ann Arbor | 1 |
Kanawha | 1 |
Phnom Penh | 1 |
Saint Louis | 1 |
Santa Clara | 1 |
Seremban | 1 |